1. US Department of Health and Human Services, Bone Health and Osteoporosis: A report of the Surgeon General. Rockville MD: U.S. Department of Health and Human Services, Office of the Surgeon General; 2004
2. Colon-Emeric CS, Kuchibhtatla M, Pieper C et al (2003) The contribution of hip fracture to risk of subsequent fractures: data from two longitudinal studies. Osteop Int 14:879–883
3. Colon-Emeric CS, Sloane R, Hawkes WG (2000) The risk of subsequent fractures in community-dwelling men and male veterans with hip fracture. Am J Med 109:324–326
4. National Osteoporosis Foundation (1998) Osteoporosis review of the evidence for prevention, diagnosis and treatment, and cost effectiveness Analysis. Osteoporos Int Suppl4:S1–S85
5. Lyles KW, Colon-Emeric CS, Magaziner J et al (2007) Efficacy and safety of Zoledronic acid 5 mg in preventing fractures in men and women with prevalent hip fractures: the horizon recurrent hip fractures trial. New Engl J Med (in press)